文献速递炎症性肠病胃肠动力与功能性疾病

药物使用与显微镜性结肠炎:病例对照研究

Medication use and microscopic colitis.
PubMed 文献 · Aliment Pharmacol Ther · 2021-09-12

本研究为病例对照研究,纳入因腹泻转诊行择期结肠镜检查的患者,排除炎症性肠病、艰难梭菌或其他感染性腹泻,由研究病理学家审核结肠活检,将患者分为显微镜性结肠炎病例组(110例)和非显微镜性结肠炎对照组(252例)。结果显示,显微镜性结肠炎与质子泵抑制剂(aOR 0.66,95%CI 0.38-1.13)或非甾体抗炎药(aOR 0.68,95%CI 0.40-1.17)使用无关;胆囊切除术在病例组中较少见(aOR 0.33,95%CI 0.17-0.64),但病例组胆囊切除术后排便次数更频繁。结论认为,与相似腹泻患者相比,显微镜性结肠炎病例并不更可能服用既往关联药物,胆囊切除术后腹泻更多提示胆汁可能参与症状或病因,对照选择对理解风险因素至关重要。

要点

  • 显微镜性结肠炎与PPI或NSAID使用无显著关联。
  • 胆囊切除术在病例组中较少见,但术后排便更频繁。
  • 对照选择对显微镜性结肠炎风险因素研究至关重要。

核心结论

  • 与相似腹泻患者相比,显微镜性结肠炎病例并不更可能服用既往关联药物。
  • 病例组胆囊切除术后腹泻更多,提示胆汁可能参与症状或病因。
  • 对照的适当选择对理解显微镜性结肠炎风险因素至关重要。

研究设计与样本

  • 病例对照研究,纳入因腹泻转诊行择期门诊结肠镜检查的患者。
  • 排除炎症性肠病、艰难梭菌或其他感染性腹泻。
  • 结肠活检由研究病理学家审核,分类为显微镜性结肠炎病例或非显微镜性结肠炎对照。
  • 研究人群包括110例显微镜性结肠炎病例和252例对照。

主要发现

  • 病例组年龄更大、受教育程度更高且更可能为女性。
  • 病例组报告更多稀便、水样便或液体便、夜间排便、便急和体重减轻。
  • 质子泵抑制剂使用与显微镜性结肠炎无关联,aOR 0.66,95%CI 0.38-1.13。
  • 非甾体抗炎药使用与显微镜性结肠炎无关联,aOR 0.68,95%CI 0.40-1.17。
  • 胆囊切除术在病例组中较少见,aOR 0.33,95%CI 0.17-0.64;但病例组胆囊切除术后排便更频繁。

临床怎么用

  • 对于因腹泻行结肠镜检查的患者,不应仅凭PPI或NSAID使用史推断显微镜性结肠炎风险。
  • 胆囊切除术后腹泻患者需考虑显微镜性结肠炎可能,胆汁可能参与症状或病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microscopic colitis is an increasingly common cause of watery diarrhoea. Several classes of medications have been associated with microscopic colitis in prior studies. AIMS: To determine the association between the use of previously implicated medications and microscopic colitis. METHODS: This was a case-control study of patients referred for elective, outpatient colonoscopy for diarrhoea. Patients were excluded for inflammatory bowel disease, C difficile, or other infectious diarrhoea. Colon biopsies were reviewed by the study pathologist and patients were classified as microscopic colitis cases or non-microscopic colitis controls. RESULTS: The study population included 110 microscopic colitis cases and 252 controls. The cases were older, better educated and more likely to be female. Cases reported a greater number of loose, watery, or liquid stools, nocturnal stools, more urgency and weight loss compared to controls. There was no association with proton pump inhibitors (PPIs), adjusted OR (aOR) 0.66, 95% CI 0.38-1.13 or nonsteroidal anti-inflammatory drugs, aOR 0.68, 95% CI 0.40-1.17. Cholecystectomy was less common in cases, aOR 0.33, 95% CI 0.17-0.64, but microscopic colitis cases had more frequent bowel movements following cholecystectomy. CONCLUSION: Compared to similar patients with diarrhoea, cases with microscopic colitis were not more likely to have taken previously implicated medications. They had more diarrhoea following cholecystectomy, suggesting that bile may play a role in symptoms or aetiology. We conclude that the appropriate choice of controls is crucial to understanding risk factors for microscopic colitis.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Sandler RS, Keku TO, Woosley JT, et al. Medication use and microscopic colitis. Aliment Pharmacol Ther. 2021. PMID: 34514632. doi:10.1111/apt.16594

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。